Advisor Group Holdings, Inc. Midatech Pharma PLC Transaction History

Advisor Group Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.46 - $1.0 $5,796 - $12,600	-12,600 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$0.83 - $1.26 $444 - $674	535 Added 4.43%	12,600 $11,000
Q3 2021 Nov 05, 2021	BUY	$1.68 - $2.19 $1,789 - $2,332	1,065 Added 9.68%	12,065 $21,000
Q2 2021 Aug 02, 2021	BUY	$1.78 - $2.95 $8,900 - $14,750	5,000 Added 83.33%	11,000 $23,000
Q1 2021 May 13, 2021	BUY	$1.92 - $3.8 $5,760 - $11,400	3,000 Added 100.0%	6,000 $13,000
Q4 2020 Feb 10, 2021	SELL	$1.77 - $2.36 $10,266 - $13,688	-5,800 Reduced 65.91%	3,000 $6,000
Q3 2020 Nov 12, 2020	BUY	$1.29 - $4.3 $7,482 - $24,940	5,800 Added 193.33%	8,800 $16,000
Q2 2020 Aug 14, 2020	BUY	$1.25 - $3.98 $3,750 - $11,940	3,000 New	3,000 $4,000

Ticker MTP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 3,939,740
Market Cap $512K
Description
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.